EIP
AVNS

Ellis Investment Partners’s Avanos Medical AVNS Stock Holding History

Ellis Investment Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27
Closed – – 241
2022
Q3 		$0 Hold
27
– – ﹤0.01% 795
2022
Q2 		$0 Hold
27
– – ﹤0.01% 785
2022
Q1 		$0 Hold
27
– – ﹤0.01% 808
2021
Q4 		$0 Hold
27
– – ﹤0.01% 796
2021
Q3 		$0 Hold
27
– – ﹤0.01% 777
2021
Q2 		$0 Hold
27
– – ﹤0.01% 775
2021
Q1 		$1K Hold
27
– – ﹤0.01% 742
2020
Q4 		$1K Hold
27
– – ﹤0.01% 712
2020
Q3 		$0 Hold
27
– – ﹤0.01% 719
2020
Q2 		$0 Hold
27
– – ﹤0.01% 704
2020
Q1 		$0 Sell
27
-44
-62% -$1.31K ﹤0.01% 715
2019
Q4 		$2K Hold
71
– – ﹤0.01% 637
2019
Q3 		$2K Hold
71
– – ﹤0.01% 662
2019
Q2 		$3K Buy
+71
New +$3.04K ﹤0.01% 601

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellis Investment Partners's AVNS Position: Q4 2022 in Review

Ellis Investment Partners sold out of Avanos Medical (AVNS) in Q4 2022, closing a stake of 27 shares.

Ellis Investment Partners first reported a position in AVNS in Q2 2019 and held it in 14 quarters. The position peaked at $3K in Q2 2019. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

  • Ellis Investment Partners reported no remaining Avanos Medical position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 27 Avanos Medical shares in Q4 2022.
  • Ellis Investment Partners first reported a position in Avanos Medical in Q2 2019 and held it in 14 quarters.
  • Ellis Investment Partners's Avanos Medical position peaked at $3K in Q2 2019.
  • 288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.